Do palliative embolization in unresectable, unsalvageable recurrent and metastatic head and neck cancer patients help?
- 3 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Archives of Oto-Rhino-Laryngology
- Vol. 278 (9), 3401-3407
- https://doi.org/10.1007/s00405-020-06505-7
Abstract
Background Bleeding from the unsalvageable recurrent and metastatic head and neck cancer is not an uncommon occurrence. It is extremely distressing for the patients and their family members and also to the treating doctors. One of the ways to manage this crisis is by selective embolization of the bleeding vessel. Methodology In this retrospective study, we audited the patients with unresectable, unsalvageable recurrent and/or metastatic head and neck cancer who underwent selective (palliative) embolization for bleeding at our institute between Jan 2015 and Nov 2019, and assessed its possible benefit in terms of bleeding free interval achieved. Results Twenty-six palliative embolization was done during the above mentioned period. The majority were male patients (n = 23, 88.4%) with a median age of 54.5 years. The performance status (PS) of most patients was 2 (n = 15, 57.6%). The most common bleeding vessel was the external carotid artery or one of its branches, most commonly lingual artery (n = 5). The bleeding vessel was identified and embolized with PVA/gel foam/coil/glue. All the procedures were uneventful. Out of 26 patients, 3 patients had another bleeding episode subsequently. Most patients had 20 days to 21 months of bleeding free interval. The cost involved in the procedure was between 400 and 2100 US dollars. Conclusions Selective embolization is an option to be considered in certain patients with unresectable, unsalvageable recurrent and/or metastatic head and neck cancer, when they present with sudden and massive bleeding to the emergency department, at centres where the facility and expertise for this procedure might be available.Keywords
This publication has 12 references indexed in Scilit:
- Head, neck, and brain tumor embolization guidelinesJournal of NeuroInterventional Surgery, 2012
- Paliatywne tamowanie krwawień w rozległych nowotworowych głowy i szyi metodą embolizacjiPolish Journal of Radiology, 2012
- Evolución en el tratamiento de los angiofibromas nasofaríngeos juvenilesActa Otorrinolaringológica Española, 2011
- Optimal treatment for recurrent/metastatic head and neck cancerAnnals of Oncology, 2010
- Safety and efficacy of vascular tumor embolization using Onyx: is angiographic devascularization sufficient?Journal of Neurosurgery, 2010
- Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy, or Chemotherapy Alone?Journal of Clinical Oncology, 2006
- Management of Bleeding in Patients with Advanced CancerThe Oncologist, 2004
- Penetrating neck trauma: A 5-year review of the literature, 1983 to 1988American Journal of Otolaryngology, 1990
- POLYVINYL ALCOHOL (IVALON)—A NEW EMBOLIC MATERIALAmerican Journal of Roentgenology, 1975
- THE TREATMENT OF TRAUMATIC ARTERIOVENOUS FISTULASouthern Medical Journal, 1930